Subscribe to Print Edition | Mon., March 10, 2008 Adar2 4, 5768 | | Israel Time: 02:12 (EST+7)
Haaretz israel news English
web haaretz.com
  Back to Homepage
Rosner's Domain
Diplomacy
Defense Jewish World Opinion National
Print Edition
Advertising
Books Arts & Leisure Business Real Estate Easy Start Travel Week's End Anglo File
Teva suffers big legal setback
By Haaretz Correspondent and Agencies , By Yoram Gabison
Tags: Teva

Teva Pharmaceuticals suffered a big loss on Friday as a U.S. federal appeals court upheld a lower court ruling that Teva had infringed on two patents held by Pfizer, Inc. on its popular Celebrex drug. The U.S. Court of Appeals for the Federal Circuit rejected claims by Teva that the two Celebrex patents at issue in the case were invalid, although it agreed with Teva that a third patent was invalid.

A U.S. district court in Newark ruled in favor of Pfizer, upholding its three main patents for Celebrex nearly a year ago.

The decision barred Teva from launching a competitor drug in the United States until December 2015.
Advertisement
This was Teva's second big legal setback in 48 hours. Last week it announced it was suing the FDA, seeking 180-day exclusivity for its copycat form of Johnson & Johnson's schizophrenia drug Risperdal, which has global annual sales of $3.5 billion.

Pfizer sued Teva in February 2004 after the generic drugmaker asked U.S. regulators for permission to sell a copycat version of Celebrex.

If Teva had won that case, it would have received six months of exclusivity on sales of the generic version of Celebrex.

Celebrex, approved in 1998, is an anti-inflammatory drug used to treat osteoarthritis and rheumatoid arthritis. It is Pfizer's second biggest revenue producer, both in the U.S. and around the world, with annual global sales of $2.3 billion. Its U.S. sales are $1.7 billion.

A Pfizer spokesman said the company was still studying the decision and could not immediately comment on its significance.

Teva shares were down 0.21% to $47.75 on Friday on the Nasdaq. Pfizer slipped 1.11% to $21.35 on the New York Stock Exchange, amid a moderate downturn for the drug sector.
Bookmark to del.icio.us  
 
State policy
Olmert approves plan for 750 new homes in West Bank settlement of Givat Ze'ev.
Sticking to his story
Director of 'Jenin, Jenin' swears there are no falsehoods in his movie.
 Today Online
Palestinians: Hamas, Hezbollah cooperated on Jerusalem attack
Responses: 183
Shin Bet chief: Chances of fresh Intifada are low
Responses: 74
Gideon Levy: Mercaz Harav produced the rabbis who led the vilest form of Zionism
Responses: 141
Editorial: Peace now, or eternal conflict later
Responses: 53
Kuwaiti analyst: Best if Israel, not U.S., destroys Iran nukes
Responses: 59
Jewish Agency to start anti-terror drive in wake of J'lem attack
Responses: 43


More Headlines
23:30 Stricken J'lem yeshiva: PM not welcome to visit
23:04 Shin Bet chief: Chances of fresh Intifada in 2008 are low
21:17 FM to U.S. envoy: Conditions not ripe for forming Palestinian state
01:46 Amos Oz: Left wing can return to power in next elections
22:48 Minister Boim accuses IAEA chief of serving as agent for Iran
22:08 'Jenin, Jenin' director tells court film based entirely on truth
00:41 Palestinians protest Goldie Hawn appearance at JNF event
18:03 PM okays 750 new settlement homes, says fits state policy
16:38 Study: Boston's intermarried 'as observant' as Reform Jews
20:21 High Court rejects petitions to overturn Ramon cabinet appointment
00:46 Second victim of ambush on IDF jeep laid to rest in Ashkelon
00:16 Holocaust museum to honor Helena Bonham Carter's grandfather for saving Jews
Previous Editions
Special Offers
Advertisement
READY FOR PURIM?
BUT - Who Will Guard The Hamentasch?
Free the Palestinians from:
Corrupt Kleptocracy, Tyrannical Theocracy, Abysmal Anarchy
Long-term Israel programs
MASA is your gateway. More programs. More grants.
NEW! Dan Boutique Jerusalem Hotel
Hip Dan Hotel in Jerusalem. Attractive Introductory Rates
7589 rockets fired so far
HELP US TO HELP THEM
FREE JEWISH HISTORY COURSE
Berel Wein's best selling lectures. 5000 Years in Five hours /CD/MP3
Marina Royale Herzelia Pituach
Your Luxurious Suite While Staying in Israel
Fattal Hotel Chain
Perfectly located hotels on best resorts of Israel.
ISRAEL BONDS Build Israel
Israel bonds - a multi-purpose way to celebrate Israel's 60th
Eldan Rent a Car
Israel's leading car rental company offers you a 20% discount on all online reservations
Junkyard
Junk a car - get free towing nationwide and a tax-deductible receipt
Home | TV | Print Edition | Diplomacy | Opinion | Arts & Leisure | Sports | Jewish World | Underground | Site rules |
Haaretz.com, the online edition of Haaretz Newspaper in Israel, offers real-time breaking news, opinions and analysis from Israel and the Middle East. Haaretz.com provides extensive and in-depth coverage of Israel, the Jewish World and the Middle East, including defense, diplomacy, the Arab-Israeli conflict, the peace process, Israeli politics, Jerusalem affairs, international relations, Iran, Iraq, Syria, Lebanon, the Palestinian Authority, the West Bank and the Gaza Strip, the Israeli business world and Jewish life in Israel and the Diaspora.
© Copyright  Haaretz. All rights reserved